Diagonal Therapeutics Funding & Investors
Cambridge, MA
Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles associated with agonist antibody drug development.
diagonaltx.comTotal Amount Raised: $128,000,000
Diagonal Therapeutics Funding Rounds
Series A
$128,000,000
Series A Investors
Atlas VentureBVF PartnersLightspeed Venture PartnersFrazier Life SciencesViking Global InvestorsCheckpoint CapitalRa Capital ManagementVelosity Capital
Funding info provided by Diffbot.